DaVita
DVA
#1689
Rank
NZ$21.70 B
Marketcap
NZ$338.22
Share price
0.91%
Change (1 day)
41.62%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$18.73. In 2025 the company made an earnings per share (EPS) of NZ$17.23 a decrease over its 2024 EPS that were of NZ$18.78.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.809.11%
2025NZ$17.23-8.25%
2024NZ$18.7844.94%
2023NZ$12.9627.26%
2022NZ$10.18-35.56%
2021NZ$15.8044.1%
2020NZ$10.9619.7%
2019NZ$9.16540.48%
2018NZ$1.43-76.07%
2017NZ$5.98-19.31%
2016NZ$7.41242.52%
2015NZ$2.16-62.87%
2014NZ$5.8213.43%
2013NZ$5.138.45%
2012NZ$4.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$41.39 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.34 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$33.11 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.29-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA